Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
501,650,900
-
Total 13F shares
-
370,125,395
-
Share change
-
-3,197,164
-
Total reported value
-
$9,840,756,595
-
Put/Call ratio
-
191%
-
Price per share
-
$26.59
-
Number of holders
-
353
-
Value change
-
-$152,293,334
-
Number of buys
-
218
-
Number of sells
-
158
Institutional Holders of Elanco Animal Health Inc - Common Stock (ELAN) as of Q3 2019
As of 30 Sep 2019,
Elanco Animal Health Inc - Common Stock (ELAN) was held by
353 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
370,125,395 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., MASSACHUSETTS FINANCIAL SERVICES CO /MA/, LAZARD ASSET MANAGEMENT LLC, Invesco Ltd., AMUNDI PIONEER ASSET MANAGEMENT INC, and STATE STREET CORP.
This page lists
356
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.